在非心血管栓塞性中风后从阿司匹林单疗转换:系统性审查和网络元分析
Aaron Rothstein1, Ossama Khazaal1, Steven Messe1
1Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia (A.R., O.K., S.M., S.E.K.).
Stroke
|December 5, 2025
概括
对于在阿司匹林治疗中经历过缺血性中风的患者,切换到替代性抗血栓治疗并没有明确减少复发性中风或心血管事件. 需要进行进一步的试验,以确定这个高风险群体的最佳二次预防策略.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 服用阿司匹林的缺血性中风患者面临二次预防困境.
- 切换抗血栓治疗的有效性是不确定的.
研究的目的:
- 系统地审查和比较用于二次中风预防的抗血栓治疗方法.
- 对患有缺血性中风的患者评估阿司匹林的替代品.
主要方法:
- 随机对照试验的系统审查和网络元分析.
- 包括9项研究 (N=5459),比较阿司匹林延续与替代品.
- 主要结局:复发性缺血性中风;次要结局:复合性血管事件.
主要成果:
- 切换疗法显示,复发性中风的相对风险是0.88 (CI 0.76-1.03) 的.
- 综合结果显示,汇总的相对风险为0.89 (CI为0.72-1.10).
- 达比加特兰,阿皮克萨班和阿司匹林+里瓦罗克萨班排名最高,但没有明显优于阿司匹林.
结论:
- 在缺血性中风后用阿司匹林切换抗血栓治疗缺乏明确的益处.
- 没有任何替代疗法比继续服用阿司匹林显著优越.
- 需要进一步的研究,以优化这一群体的二次预防.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


